Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence.
Wildiers H, Dirix L, Neven P, Prové A, Clement P, Squifflet P, Amant F, Skacel T, Paridaens R. Wildiers H, et al. Among authors: prove a. Breast Cancer Res Treat. 2009 Mar;114(1):103-12. doi: 10.1007/s10549-008-9970-z. Epub 2008 Mar 16. Breast Cancer Res Treat. 2009. PMID: 18344024 Clinical Trial.
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Dirix L, Catimel G, Koier I, Provè A, Schrijvers D, Joossens E, De Bruijn E, Ardiet C, Evene E, Dumortier A, et al. Dirix L, et al. Among authors: prove a. Anticancer Drugs. 1995 Feb;6(1):53-63. doi: 10.1097/00001813-199502000-00006. Anticancer Drugs. 1995. PMID: 7756684 Clinical Trial.
Coping with toxicities of docetaxel (Taxotere).
Schrijvers D, Wanders J, Dirix L, Prove A, Vonck I, van Oosterom A, Kaye S. Schrijvers D, et al. Among authors: prove a. Ann Oncol. 1993 Aug;4(7):610-1. doi: 10.1093/oxfordjournals.annonc.a058599. Ann Oncol. 1993. PMID: 8103352 Free article. Clinical Trial.
The management of ovarian cancer.
Prové AM, Dirix LY, Schrijvers D, Van Oosterom AT. Prové AM, et al. Ann Oncol. 1993 Dec;4(10):883-7. doi: 10.1093/oxfordjournals.annonc.a058398. Ann Oncol. 1993. PMID: 8117609 Free article. No abstract available.
High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment.
Kvinnsland S, Anker G, Dirix LY, Bonneterre J, Prove AM, Wilking N, Lobelle JP, Mariani O, di Salle E, Polli A, Massimini G. Kvinnsland S, et al. Among authors: prove am. Eur J Cancer. 2000 May;36(8):976-82. doi: 10.1016/s0959-8049(00)00041-1. Eur J Cancer. 2000. PMID: 10885600 Clinical Trial.
31 results